Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate ; day:19 ; month:12 ; year:2022 ; pages:1-12
Rheumatology and therapy ; (19.12.2022), 1-12
- Urheber
-
Fleischmann, Roy
Haraoui, Boulos
Buch, Maya H.
Gold, David
Sawyerr, Gosford
Shi, Harry
Diehl, Annette
Lee, Kristen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40744-022-00511-3
- URN
-
urn:nbn:de:101:1-2023030121003030472669
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fleischmann, Roy
- Haraoui, Boulos
- Buch, Maya H.
- Gold, David
- Sawyerr, Gosford
- Shi, Harry
- Diehl, Annette
- Lee, Kristen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Methotrexate
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
Potential neurotoxicity associated with methotrexate
Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate
Methotrexate-Associated Lymphoproliferative Disorder with Intraocular Involvement Improved with Intravitreal Methotrexate and Chemotherapy: A Case Report
Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate: a post hoc analysis of data from ORAL Strategy
Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis
High-dose Methotrexate
METHOTREXATE INDUCED LEUCOENCEPHALOPATHY
Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Unsuccessful Treatment of Cheilitis Granulomatosa with Oral Methotrexate
Methotrexate
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
Potential neurotoxicity associated with methotrexate
Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate
Methotrexate-Associated Lymphoproliferative Disorder with Intraocular Involvement Improved with Intravitreal Methotrexate and Chemotherapy: A Case Report
Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate: a post hoc analysis of data from ORAL Strategy
Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis
High-dose Methotrexate
METHOTREXATE INDUCED LEUCOENCEPHALOPATHY
Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Unsuccessful Treatment of Cheilitis Granulomatosa with Oral Methotrexate
Methotrexate
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
Potential neurotoxicity associated with methotrexate
Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate
Methotrexate-Associated Lymphoproliferative Disorder with Intraocular Involvement Improved with Intravitreal Methotrexate and Chemotherapy: A Case Report
Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate: a post hoc analysis of data from ORAL Strategy
Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis
High-dose Methotrexate
METHOTREXATE INDUCED LEUCOENCEPHALOPATHY
Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay